{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:14:30Z","timestamp":1788952470090,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bbrc.2026.154436","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T23:13:34Z","timestamp":1786576414000},"page":"154436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Synthesis, and biological evaluation of novel 4-thiazolidinone derivatives as promising antidiabetic agents: In silico and in vivo investigations"],"prefix":"10.1016","volume":"834","author":[{"given":"Banylla Felicity","family":"DkharGatphoh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amgoth","family":"Ramesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poornachandra Shamanna","family":"Prabhakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madan","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha N.","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwini","family":"Somayaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaithra","family":"Raviraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheshagiri R.","family":"Dixit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1331-4642","authenticated-orcid":false,"given":"Durgesh Paresh","family":"Bidye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5458-2451","authenticated-orcid":false,"given":"B.C.","family":"Revanasiddappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.154436_bib1","first-page":"698","article-title":"Epidemiology of diabetes","volume":"42","author":"Forouhi","year":"2014","journal-title":"Medicine (United Kingdom)"},{"key":"10.1016\/j.bbrc.2026.154436_bib2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2337\/diaclin.26.2.77","article-title":"Microvascular and macrovascular complications of diabetes","volume":"26","author":"Fowler","year":"2008","journal-title":"Clin. Diabetes"},{"key":"10.1016\/j.bbrc.2026.154436_bib3","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S2213-8587(18)30052-4","article-title":"Precision medicine in the management of type 2 diabetes","volume":"6","author":"Gloyn","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.bbrc.2026.154436_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-018-4711-2","article-title":"Global trends in diabetes complications: a review of current evidence","volume":"62","author":"Harding","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbrc.2026.154436_bib5","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.2174\/1381612825666190717104547","article-title":"Recent developments in alpha-glucosidase inhibitors for management of Type-2 diabetes: an update","volume":"25","author":"Usman","year":"2019","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbrc.2026.154436_bib6","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ejmech.2019.01.067","article-title":"Role of PPAR receptor in different diseases and their ligands: physiological importance and clinical implications","volume":"166","author":"Mirza","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbrc.2026.154436_bib7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.biochi.2016.12.019","article-title":"The role and regulation of the peroxisome proliferator activated receptor alpha in human liver","volume":"136","author":"Kersten","year":"2017","journal-title":"Biochimie"},{"key":"10.1016\/j.bbrc.2026.154436_bib8","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2174\/156800605774370362","article-title":"Role of PPAR-; agonist thiazolidinediones in treatment of pre-diabetic and diabetic individuals: a cardiovascular perspective","volume":"5","author":"Dumasia","year":"2005","journal-title":"Curr. Drug Targets - Cardiovasc. Hematol. Disord."},{"key":"10.1016\/j.bbrc.2026.154436_bib9","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4103\/2231-4040.90879","article-title":"The peroxisome proliferator-activated receptor: a family of nuclear receptors role in various diseases","volume":"2","author":"Tyagi","year":"2011","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"10.1016\/j.bbrc.2026.154436_bib10","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.coph.2006.06.009","article-title":"PPAR\u03b1 and PPAR\u03b3 dual agonists for the treatment of type 2 diabetes and the metabolic syndrome","volume":"6","author":"Fievet","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.154436_bib11","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1021\/jm990554g","article-title":"The PPARs: from orphan receptors to drug discovery","volume":"43","author":"Willson","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2026.154436_bib12","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.ejmech.2010.01.007","article-title":"Derivatives of benzimidazole pharmacophore: synthesis, anticonvulsant, antidiabetic and DNA cleavage studies","volume":"45","author":"Shingalapur","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbrc.2026.154436_bib13","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ejmech.2016.12.020","article-title":"Thiazolidinediones and PPAR orchestra as antidiabetic agents: from past to present","volume":"126","author":"Yasmin","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbrc.2026.154436_bib14","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cbi.2016.12.008","article-title":"Study of novel anticancer 4-thiazolidinone derivatives","volume":"262","author":"Szychowski","year":"2017","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bbrc.2026.154436_bib15","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.bbrc.2020.09.144","article-title":"Rosiglitazone ameliorates skeletal muscle insulin resistance by decreasing free fatty acids release from adipocytes","volume":"533","author":"Gong","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2026.154436_bib16","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1002\/hep.32012","article-title":"Thiazolidinediones and glucagon\u2010like Peptide\u20101 receptor agonists and the risk of nonalcoholic Fatty liver disease: a cohort study","volume":"74","author":"van Dalem","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2026.154436_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103927","article-title":"The antidiabetic drug lobeglitazone has the potential to inhibit PTP1B activity","volume":"100","author":"Rocha","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bbrc.2026.154436_bib18","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3892\/mmr.2021.12069","article-title":"The antidiabetic drug troglitazone protects against PrP (106-126)-induced neurotoxicity via the PPAR\u03b3-autophagy pathway in neuronal cells","volume":"23","author":"Moon","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbrc.2026.154436_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.137657","article-title":"Design, synthesis, characterization, and biological evaluation of novel pyrazine-1,3,4-oxadiazole\/[1,2,4] triazolo[3,4-b][1,3,4]thiadiazine hybrids as potent antimycobacterial agents","volume":"1304","author":"kumar","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bbrc.2026.154436_bib20","doi-asserted-by":"crossref","first-page":"8194","DOI":"10.1021\/jm0506930","article-title":"Novel indole-based peroxisome proliferator-activated receptor agonists: design, SAR, structural biology, and biological activities","volume":"48","author":"Mahindroo","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2026.154436_bib21","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.bioorg.2018.10.025","article-title":"Novel hybrids of benzothiazole-1,3,4-oxadiazole-4-thiazolidinone: synthesis, in silico ADME study, molecular docking and in vivo anti-diabetic assessment","volume":"83","author":"Bhutani","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bbrc.2026.154436_bib22","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.4155\/fmc-2017-0191","article-title":"Synthesis and evaluation of thiazolidinone-pyrazole conjugates as anticancer and antimicrobial agents","volume":"10","author":"Bhat","year":"2018","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bbrc.2026.154436_bib23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.53879\/id.59.03.12584","article-title":"SYNTHESIS, computational and in vitro anti-diabetic studies of novel THIAZOLIDIN-4-ONES derivatives","volume":"59","author":"Gatphoh","year":"2022","journal-title":"Indian Drugs"},{"key":"10.1016\/j.bbrc.2026.154436_bib24","first-page":"519","article-title":"Synthesis, molecular docking, MD simulation and evaluation of anticancer activity of novel 1,3,4-Oxadiazole derivatives against ehrlich ascites carcinoma (EAC) cell lines","volume":"23","author":"Deshpande","year":"2024","journal-title":"JCBC"},{"key":"10.1016\/j.bbrc.2026.154436_bib25","unstructured":"Guidelines for the Testing of Chemicals | OECD, (n.d.). https:\/\/www.oecd.org\/en\/topics\/sub-issues\/testing-of-chemicals\/test-guidelines.html (accessed July 10, 2025)."},{"key":"10.1016\/j.bbrc.2026.154436_bib26","unstructured":"Anti-diabetic potential of Artemisia monosperma Delile extract related to anti-inflammatory, antioxidant, and wound-healing properties | Sci. Rep., (n.d.). https:\/\/www.nature.com\/articles\/s41598-026-50561-8 (accessed July 17, 2026)."},{"key":"10.1016\/j.bbrc.2026.154436_bib27","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.bioorg.2018.10.025","article-title":"Novel hybrids of benzothiazole-1,3,4-oxadiazole-4-thiazolidinone: synthesis, in silico ADME study, molecular docking and in vivo anti-diabetic assessment","volume":"83","author":"Bhutani","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bbrc.2026.154436_bib28","unstructured":"Development of novel thiazolidine-2,4-dione derivatives as PPAR-\u03b3 agonists through design, synthesis, computational docking, MD simulation, and comprehensive in vitro and in vivo evaluation\u2020 | RSC Med. Chem. The Royal Soc. Chem., (n.d.). https:\/\/pubs.rsc.org\/md\/article-abstract\/14\/11\/2401\/812999\/Development-of-novel-thiazolidine-2-4-dione?redirectedFrom=fulltext (accessed July 16, 2026)."},{"key":"10.1016\/j.bbrc.2026.154436_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154887","article-title":"Quercetin: a promising therapy for diabetic encephalopathy through inhibition of hippocampal ferroptosis","volume":"126","author":"Cheng","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bbrc.2026.154436_bib30","article-title":"The signaling pathways of selected traditional Chinese medicine prescriptions and their metabolites in the treatment of diabetic cardiomyopathy: a review","volume":"15","author":"Li","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.154436_bib31","doi-asserted-by":"crossref","first-page":"10121","DOI":"10.1039\/D2FO02300H","article-title":"Hypoglycemic effect of the polysaccharides from Astragalus membranaceus on type 2 diabetic mice based on the \u201cgut microbiota\u2013mucosal barrier,\u201d","volume":"13","author":"Chen","year":"2022","journal-title":"Food Funct."},{"key":"10.1016\/j.bbrc.2026.154436_bib32","doi-asserted-by":"crossref","first-page":"11929","DOI":"10.1021\/acs.jafc.3c02429","article-title":"Dendrobium officinale polysaccharide alleviates type 2 diabetes Mellitus by restoring gut Microbiota and repairing intestinal barrier via the LPS\/TLR4\/TRIF\/NF-kB axis","volume":"71","author":"Chen","year":"2023","journal-title":"J. Agric. Food Chem."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26012003?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26012003?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:35:19Z","timestamp":1788950119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26012003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":32,"alternative-id":["S0006291X26012003"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154436","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis, and biological evaluation of novel 4-thiazolidinone derivatives as promising antidiabetic agents: In silico and in vivo investigations","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154436","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154436"}}